Earnings
TLC announced financial results for the fourth quarter and full year ended December 31, 2018, and provided a business update.
GeoVax Labs, Inc., a biotechnology company developing human vaccines, announced its financial results for the year ended December 31, 2018.
Epigenomics AG announced the financial results for the year ended December 31, 2018.
Conference call and webcast, March 27, 2019 at 3pm CET (Frankfurt) / 10am EST (New York)
Soligenix, Inc announced its recent accomplishments and financial results for the year ended December 31, 2018.
Heidelberg Pharma AG published its financial results and annual report for fiscal year 2018 and its outlook for 2019.
Interim data from all patients enrolled in ongoing L-MIND trial of MOR208 in combination with lenalidomide in relapsed/refractory DLBCL confirm activity suggested by earlier data cuts
A turnover of €47.4 million, including €37.1 million related to the partnership signed with the Chinese company Tonghua Dongbao and €10.3 million following the judgment rendered in favor of Adocia in the first phase of the arbitration against Eli Lilly & Co
Oxford Immunotec, a global, high-growth diagnostics company, today announced fourth quarter and full year 2018 financial results.
Board Authorizes $6 Billion for Share Repurchases
PRESS RELEASES